Literature DB >> 23543409

Generation of c-Myc transgenic pigs for autosomal dominant polycystic kidney disease.

Jianhua Ye1, Jin He, Qiuyan Li, Yuanyuan Feng, Xueyuan Bai, Xiangmei Chen, Yaofeng Zhao, Xiaoxiang Hu, Zhengquan Yu, Ning Li.   

Abstract

After several decades of research, autosomal dominant polycystic kidney disease (ADPKD) is still incurable and imposes enormous physical, psychological, and economic burdens on patients and their families. Murine models of ADPKD represent invaluable tools for studying this disease. These murine forms of ADPKD can arise spontaneously, or they can be induced via chemical or genetic manipulations. Although these models have improved our understanding of the etiology and pathogenesis of ADPKD, they have not led to effective treatment strategies. The mini-pig represents an effective biomedical model for studying human diseases, as the pig's human-like physiological processes help to understand disease mechanisms and to develop novel therapies. Here, we tried to generate a transgenic model of ADPKD in pigs by overexpressing c-Myc in kidney tissue. Western-blot analysis showed that c-Myc was overexpressed in the kidney, brain, heart, and liver of transgenic pigs. Immunohistochemical staining of kidney tissue showed that exogenous c-Myc predominantly localized to renal tubules. Slightly elevated blood urea nitrogen levels were observed in transgenic pigs 1 month after birth, but no obvious abnormalities were detected after that time. In the future, we plan to subject this model to renal injury in an effort to promote ADPKD progression.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23543409     DOI: 10.1007/s11248-013-9707-6

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  62 in total

1.  Immunoblotting: submerged electrophoretic transfer of proteins from gels to membranes.

Authors:  Ed Harlow; David Lane
Journal:  CSH Protoc       Date:  2006-06-01

Review 2.  Autosomal dominant polycystic kidney disease.

Authors:  Vicente E Torres; Peter C Harris; Yves Pirson
Journal:  Lancet       Date:  2007-04-14       Impact factor: 79.321

3.  Third-hit signaling in renal cyst formation.

Authors:  Thomas Weimbs
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

4.  The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.

Authors:  F Qian; T J Watnick; L F Onuchic; G G Germino
Journal:  Cell       Date:  1996-12-13       Impact factor: 41.582

5.  The metabolic profile of tumors depends on both the responsible genetic lesion and tissue type.

Authors:  Mariia O Yuneva; Teresa W M Fan; Thaddeus D Allen; Richard M Higashi; Dana V Ferraris; Takashi Tsukamoto; José M Matés; Francisco J Alonso; Chunmei Wang; Youngho Seo; Xin Chen; J Michael Bishop
Journal:  Cell Metab       Date:  2012-02-08       Impact factor: 27.287

6.  Disappearance of polycystic kidney disease in revertant c-myc transgenic mice.

Authors:  M Trudel; N Chrétien; V D'Agati
Journal:  Mamm Genome       Date:  1994-03       Impact factor: 2.957

7.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

8.  Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia/reperfusion.

Authors:  Ana P Bastos; Klaus Piontek; Ana M Silva; Dino Martini; Luis F Menezes; Jonathan M Fonseca; Ivone I Fonseca; Gregory G Germino; Luiz F Onuchic
Journal:  J Am Soc Nephrol       Date:  2009-10-15       Impact factor: 10.121

9.  A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1.

Authors:  Klaus Piontek; Luis F Menezes; Miguel A Garcia-Gonzalez; David L Huso; Gregory G Germino
Journal:  Nat Med       Date:  2007-10-28       Impact factor: 53.440

10.  Germinal and somatic mutations in the PKD2 gene of renal cysts in autosomal dominant polycystic kidney disease.

Authors:  M Koptides; C Hadjimichael; P Koupepidou; A Pierides; C Constantinou Deltas
Journal:  Hum Mol Genet       Date:  1999-03       Impact factor: 6.150

View more
  6 in total

Review 1.  Genetically modified pigs to model human diseases.

Authors:  Tatiana Flisikowska; Alexander Kind; Angelika Schnieke
Journal:  J Appl Genet       Date:  2014-02       Impact factor: 3.240

2.  Generation of AQP2-Cre transgenic mini-pigs specifically expressing Cre recombinase in kidney collecting duct cells.

Authors:  Weiwei Luo; Zhanjun Li; Yongye Huang; Yang Han; Chaogang Yao; Xinping Duan; Hongsheng Ouyang; Li Li
Journal:  Transgenic Res       Date:  2013-12-05       Impact factor: 2.788

Review 3.  An Overview of In Vivo and In Vitro Models for Autosomal Dominant Polycystic Kidney Disease: A Journey from 3D-Cysts to Mini-Pigs.

Authors:  Svenja Koslowski; Camille Latapy; Pierrïck Auvray; Marc Blondel; Laurent Meijer
Journal:  Int J Mol Sci       Date:  2020-06-25       Impact factor: 5.923

4.  The ciliary protein cystin forms a regulatory complex with necdin to modulate Myc expression.

Authors:  Maoqing Wu; Chaozhe Yang; Binli Tao; Su Bu; Lisa M Guay-Woodford
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

5.  Genetic characteristics of polycistronic system‑mediated randomly‑inserted multi‑transgenes in miniature pigs and mice.

Authors:  Siyuan Kong; Li Li; Wenjuan Zhu; Leilei Xin; Jinxue Ruan; Yubo Zhang; Shulin Yang; Kui Li
Journal:  Mol Med Rep       Date:  2017-10-20       Impact factor: 2.952

6.  Identification of ADPKD-Related Genes and Pathways in Cells Overexpressing PKD2.

Authors:  Zhe Zhang; Yanna Dang; Zizengceng Wang; Huanan Wang; Yuchun Pan; Jin He
Journal:  Genes (Basel)       Date:  2020-01-22       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.